RxDoctor Payments Data

Khawar Malik, DPM

Foot & Ankle Surgery · Noblesville, INNPI 1295176493

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.6%), education and consulting fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Osteomed LLC at 30.1% of the total. Reporting peaked in 2019 at $15,972 and has fallen 96.9% since, to $489 in 2025.

$22,422in general payments, 2019–2025

Across 71 payments — averaging $315.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Osteomed LLC$7K
  • Crossroads Orthopedics, LLC$6K
  • Ortho Solutions Inc$2K
  • Trilliant Surgical LLC.$2K
  • Extremity Medical$2K
  • Skye Orthobiologics LLC$1K
  • plus $2K from 24 others

What the payments were for

  • Consulting fees$3,60016%
  • Speaking & faculty fees$9,99545%
  • Travel & lodging$3962%
  • Food & beverage$1,9869%
  • Education$6,44529%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,422 in reported general payments places this provider in the 85th percentile of 212 foot & ankle surgery providers in Indiana.

See all foot & ankle surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$120,656
Medicare patients
275
Services billed
1,447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin34$361
Doxycycline Hyclate22$241
Methylprednisolone23$108
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$80

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Noblesville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →